At a glance
- Originator Taisho Pharmaceutical
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Vascular dementia
Most Recent Events
- 24 Jan 1996 Discontinued-Preclinical for Alzheimer's disease in Japan (Unknown route)
- 24 Jan 1996 Discontinued-Preclinical for Vascular dementia in Japan (Unknown route)